DEFINITION of 'Bioequivalence'

Bioequivalence is the similarity of two drugs that share the same desired outcome for patients. Pharmaceutical equivalence means two drugs release the active ingredient into the bloodstream at the same amount and same rate. When assessing how well a generic drug works, scientists evaluate its bioequivalence to the name-brand version.

BREAKING DOWN 'Bioequivalence'

Bioequivalence is determined by pharmacokinetic studies to determine whether a commercially available brand product and a potential to market generic version share core attributes. For a generic drug manufacturer to get the U.S. Food and Drug Administration’s (FDA) stamp of approval, they must prove it is pharmaceutically equal to the name-brand version. A drug maker must also get FDA approval before marketing or selling a different version of an approved drug. For example, it must prove a once-a-week tablet is bioequivalent to a daily tablet.

In addition, the FDA has different bioequivalence standards depending on whether the drug is taken as a pill, injection, patch, inhaler or through another method. When a generic drug is not bioequivalent to the name-brand version, it might still be approved for another use, but not be approved as a substitute for the name-brand version.

Unlike their name-brand counterparts, generic drugs usually don’t need to go through the full clinical trial process to get approved because generic drugs only have to be bioequivalent. The company applying for approval to market the generic drug must only test the generic drug against the brand-name drug on two small groups of test subjects, draw timed blood samples from each patient, and show through statistical analysis that any difference in the drug’s bioavailability in participants taking the brand name version versus participants taking the generic version is not clinically significant.

It is easier to make a bioequivalent form of a traditional pill or injectable drug than to make a bioequivalent form of a biologic drug. As a result, the generic versions of biologic drugs, called “biosimilars,” may have to undergo clinical trials to gain approval.

"Bioequivalence" Issues

While bioequivalent drugs offer patients many benefits, some concerns still remain. Bioequivalence problems have been reported by physicians and patients that many approved generic drugs do not have the same desired impact as the branded counterparts. Certain classes are more prone to these discrepancies from specific chemical reactions. Some of these include poorly absorbed drugs, chiral drugs and other complex delivery mechanisms. Physicians are cautious in switching patients from branded to generic products, or between different generic manufacturers when prescribing ant-epileptic drugs and blood thinners.

RELATED TERMS
  1. Orange Book

    The Orange Book is a list of drugs that the U.S. Food and Drug ...
  2. New Drug Application (NDA)

    The New Drug Application (NDA) is the formal final step taken ...
  3. Side Effect

    Side effect is a negative or undesirable symptom or condition ...
  4. Orphan Drug

    Orphan drug is a medication or biological product that treats ...
  5. Blockbuster Drug

    A blockbuster drug is an extremely popular drug that generates ...
  6. Investigational New Drug (IND)

    An Investigational New Drug (IND) application is the first step ...
Related Articles
  1. Investing

    Market Vectors Launches First Generic Drugs ETF (GNRX)

    Generic drugs have been a growing market in recent years. Now there is an ETF targeted at this market.
  2. Insights

    Why Are Prescription Drug Prices So High?

    Expensive drugs that don’t have affordable alternatives or generic equivalents are a serious concern today. So why are prescription drug prices so high?
  3. Insights

    Drug Prices Gone Wild: Hospitals Feel Pain of Increases

    Hospitals and patients are suffering as prices soar for both branded and generic drugs
  4. Investing

    Drug Approvals Fell to Six-Year Low in 2016

    New drug approvals dropped to modest levels in 2016 following highs in 2014 and 2015.
  5. Investing

    Pharma Balks at German Price Control (BAYRY, RHHBY)

    Drug makers are worried about a proposed new German law that would tighten price controls on prescription drugs.
  6. Investing

    Using DCF In Biotech Valuation

    Valuing firms in this sector can seem like a black art, but there is a systematic way to pin a price on potential.
  7. Investing

    Where Does the US Get Its Supply of Drugs?

    Despite increasing demands for local production, the US imports only a small portion of its drugs.
  8. Financial Advisor

    8 Hacks for Scoring Cheaper Prescription Drugs

    The rising cost of prescription drugs has caused many patients to scramble for funds. Here's what you can do to help clients lower pharmacy costs.
  9. Trading

    5 Generic Products That Are Just As Good

    While some generic products are second-rate, others are just as good as the real thing. Here are six generics that take the cake.
  10. Insurance

    The Cancer (and Other Drug) Shortage

    Your doctor may not tell you, but even in the U.S., life-saving drugs can be in short supply. Here's what to know and do.
RELATED FAQS
  1. How does the profit margin compare for a generic drug versus a brand name drug?

    Learn how the profit margins compare for generic drugs and brand-name drugs. Brand-name drugs cost three to four times more ... Read Answer >>
  2. What are the major barriers to entry for new companies in the drugs sector?

    Find out why barriers to entry for U.S. drug companies are so high and how the Food and Drug Administration, or FDA, inhibits ... Read Answer >>
  3. How does government regulation impact the drugs sector?

    Learn about how drugs are regulated by the U.S. government as well as the role of the Food and Drug Administration during ... Read Answer >>
  4. Do financial advisors get drug tested?

    Learn how financial advisor regulatory bodies do not require drug testing but many individual firms that hire advisors do ... Read Answer >>
  5. Can your insurance company drug test you?

    Learn why drug companies conduct drug tests and how a lifestyle free of drugs and alcohol can save you big money on health ... Read Answer >>
  6. What is the average price-to-earnings ratio in the drugs sector?

    Learn what the average price-to-earnings ratio is for companies operating in the drugs sector and why this metric is important ... Read Answer >>
Hot Definitions
  1. Investment Advisor

    An investment advisor is any person or group that makes investment recommendations or conducts securities analysis in return ...
  2. Gross Margin

    A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. ...
  3. Inflation

    Inflation is the rate at which prices for goods and services is rising and the worth of currency is dropping.
  4. Discount Rate

    Discount rate is the interest rate charged to commercial banks and other depository institutions for loans received from ...
  5. Economies of Scale

    Economies of scale refer to reduced costs per unit that arise from increased total output of a product. For example, a larger ...
  6. Quick Ratio

    The quick ratio measures a company’s ability to meet its short-term obligations with its most liquid assets.
Trading Center